SK72399A3 - Pharmaceutical composition - Google Patents
Pharmaceutical composition Download PDFInfo
- Publication number
- SK72399A3 SK72399A3 SK723-99A SK72399A SK72399A3 SK 72399 A3 SK72399 A3 SK 72399A3 SK 72399 A SK72399 A SK 72399A SK 72399 A3 SK72399 A3 SK 72399A3
- Authority
- SK
- Slovakia
- Prior art keywords
- water
- composition
- oil
- suspension
- ceftiofur
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/806,584 US5736151A (en) | 1996-12-09 | 1996-12-09 | Antibiotic oil suspensions |
| PCT/US1997/021401 WO1998025621A1 (en) | 1996-12-09 | 1997-12-03 | Improved pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK72399A3 true SK72399A3 (en) | 2000-05-16 |
Family
ID=25194373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK723-99A SK72399A3 (en) | 1996-12-09 | 1997-12-03 | Pharmaceutical composition |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5736151A (https=) |
| EP (1) | EP0941095B1 (https=) |
| JP (1) | JP2001505910A (https=) |
| KR (1) | KR100544248B1 (https=) |
| CN (1) | CN100413506C (https=) |
| AT (1) | ATE264681T1 (https=) |
| AU (1) | AU746666B2 (https=) |
| BR (1) | BR9714967B1 (https=) |
| CA (1) | CA2269682C (https=) |
| CZ (1) | CZ297632B6 (https=) |
| DE (1) | DE69728783T2 (https=) |
| DK (1) | DK0941095T3 (https=) |
| ES (1) | ES2218705T3 (https=) |
| FI (1) | FI991302A0 (https=) |
| HU (1) | HUP0000564A3 (https=) |
| NO (1) | NO325475B1 (https=) |
| NZ (1) | NZ336183A (https=) |
| PL (1) | PL190662B1 (https=) |
| PT (1) | PT941095E (https=) |
| SK (1) | SK72399A3 (https=) |
| WO (1) | WO1998025621A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002022107A2 (en) * | 2000-09-12 | 2002-03-21 | Pharmacia & Upjohn Company | Pharmaceutical composition having modified carrier |
| US7829100B2 (en) * | 2000-09-12 | 2010-11-09 | Teagarden Dirk L | Pharmaceutical composition having modified carrier |
| KR100423895B1 (ko) * | 2001-02-19 | 2004-03-24 | 주식회사 엘지생명과학 | 셉티오퍼 하이드로클로라이드의 현탁제 조성물 |
| US20040022815A1 (en) * | 2002-08-05 | 2004-02-05 | Orchid Health Care | Novel pharmaceutical composition of ceftiofur |
| AU2002328168B2 (en) * | 2002-08-07 | 2008-08-21 | Merial Ltd. | Novel pharmaceutical composition of ceftiofur |
| KR20040015622A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
| US7659061B2 (en) * | 2002-11-19 | 2010-02-09 | Pharmacia & Upjohn Company | Pharmaceutical compositions having a modified vehicle |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| PL1608407T3 (pl) * | 2003-03-20 | 2006-12-29 | Pharmacia Corp | Dyspergowana kompozycja środka przeciw-zapalnego |
| JP2007500692A (ja) * | 2003-07-31 | 2007-01-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 乳房炎及び耳障害を治療するための分散性医薬組成物 |
| WO2006008640A1 (en) * | 2004-07-15 | 2006-01-26 | Pharmacia & Upjohn Company Llc | Non-aqueous suspension containing a drug having an unpleasant taste |
| CZ300590B6 (cs) * | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| CZ300424B6 (cs) * | 2006-06-20 | 2009-05-13 | Pliva - Lachema A. S. | Farmaceutická kompozice pro perorální podání |
| US8309138B2 (en) | 2007-02-16 | 2012-11-13 | Aska Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising microparticle oily suspension |
| CN101406447B (zh) * | 2007-10-12 | 2010-08-25 | 河南农业大学 | 复方头孢噻呋油混悬注射液制备工艺 |
| WO2010040055A2 (en) * | 2008-10-03 | 2010-04-08 | Intekrin Therapeutics, Inc. | Oral pharmaceutical formulations for antidiabetic compounds |
| EP2367572B1 (en) * | 2008-11-19 | 2018-08-29 | Merial, Inc. | Formulations comprising ceftiofur and benzyl alcohol |
| LT2874624T (lt) | 2012-07-17 | 2019-12-10 | Bayer New Zealand Ltd | Injekuojamos antibiotikų kompozicijos ir jų panaudojimo būdai |
| FR3000392B1 (fr) | 2012-12-27 | 2015-03-27 | Virbac | Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation |
| US9956164B2 (en) | 2014-04-16 | 2018-05-01 | Veyx-Pharma Gmbh | Veterinary pharmaceutical composition and use thereof |
| EA201791982A1 (ru) | 2015-03-09 | 2020-02-17 | Интекрин Терапьютикс, Инк. | Способы лечения неалкогольной жировой болезни печени и/или липодистрофии |
| WO2018071810A1 (en) * | 2016-10-13 | 2018-04-19 | RhinoNase, Inc. | Antibiotic compositions for nasal irrigation and methods |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
| CN113209015A (zh) * | 2020-01-21 | 2021-08-06 | 江西邦诚动物药业有限公司 | 长效盐酸头孢噻呋混悬注射液及其制备工艺 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB914894A (en) * | 1960-08-12 | 1963-01-09 | Beecham Res Lab | Injectable pharmaceutical media |
| NL260648A (https=) * | 1961-01-31 | |||
| US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
| FR2479229B1 (fr) * | 1980-03-26 | 1986-01-17 | Clin Midy | Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives |
| US4902683A (en) * | 1984-10-25 | 1990-02-20 | The Upjohn Company | Crystalline cephalosporin hydrohalide salts |
| DE3650526T2 (de) * | 1985-08-12 | 1996-10-31 | Upjohn Co | Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz |
| AU617377B2 (en) * | 1987-11-10 | 1991-11-28 | Pharmacia & Upjohn Company | Cephalosporin antibiotics |
| US5223496A (en) * | 1987-11-10 | 1993-06-29 | The Upjohn Company | Cephalosporin antibiotics |
| US4877782A (en) * | 1988-02-16 | 1989-10-31 | The Upjohn Company | Zinc ceftiofur complexes |
| CA2060501A1 (en) * | 1989-06-13 | 1990-12-14 | Akwete Adjei | Anhydrous oil-based liquid suspension for delivering a medicament |
| US5721359A (en) * | 1993-03-12 | 1998-02-24 | Pharmacia & Upjohn Company | Crystalline ceftiofur free acid |
-
1996
- 1996-12-09 US US08/806,584 patent/US5736151A/en not_active Expired - Lifetime
-
1997
- 1997-12-03 SK SK723-99A patent/SK72399A3/sk unknown
- 1997-12-03 KR KR1019997005069A patent/KR100544248B1/ko not_active Expired - Fee Related
- 1997-12-03 JP JP52669998A patent/JP2001505910A/ja active Pending
- 1997-12-03 PT PT97948461T patent/PT941095E/pt unknown
- 1997-12-03 HU HU0000564A patent/HUP0000564A3/hu unknown
- 1997-12-03 AT AT97948461T patent/ATE264681T1/de not_active IP Right Cessation
- 1997-12-03 WO PCT/US1997/021401 patent/WO1998025621A1/en not_active Ceased
- 1997-12-03 BR BRPI9714967-5A patent/BR9714967B1/pt not_active IP Right Cessation
- 1997-12-03 DK DK97948461T patent/DK0941095T3/da active
- 1997-12-03 CN CNB971801495A patent/CN100413506C/zh not_active Expired - Lifetime
- 1997-12-03 NZ NZ336183A patent/NZ336183A/xx not_active IP Right Cessation
- 1997-12-03 AU AU54529/98A patent/AU746666B2/en not_active Expired
- 1997-12-03 EP EP97948461A patent/EP0941095B1/en not_active Revoked
- 1997-12-03 DE DE69728783T patent/DE69728783T2/de not_active Revoked
- 1997-12-03 CA CA002269682A patent/CA2269682C/en not_active Expired - Lifetime
- 1997-12-03 CZ CZ0202599A patent/CZ297632B6/cs not_active IP Right Cessation
- 1997-12-03 PL PL97333790A patent/PL190662B1/pl not_active IP Right Cessation
- 1997-12-03 ES ES97948461T patent/ES2218705T3/es not_active Expired - Lifetime
- 1997-12-03 FI FI991302A patent/FI991302A0/fi not_active Application Discontinuation
-
1999
- 1999-06-08 NO NO19992780A patent/NO325475B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE264681T1 (de) | 2004-05-15 |
| HK1023292A1 (zh) | 2000-09-08 |
| FI991302A7 (fi) | 1999-06-08 |
| PL190662B1 (pl) | 2005-12-30 |
| HUP0000564A3 (en) | 2001-01-29 |
| DK0941095T3 (da) | 2004-08-02 |
| CZ202599A3 (cs) | 1999-09-15 |
| DE69728783D1 (de) | 2004-05-27 |
| NO325475B1 (no) | 2008-05-13 |
| BR9714967B1 (pt) | 2010-06-29 |
| FI991302L (fi) | 1999-06-08 |
| BR9714967A (pt) | 2001-10-30 |
| CA2269682A1 (en) | 1998-06-18 |
| PT941095E (pt) | 2004-08-31 |
| JP2001505910A (ja) | 2001-05-08 |
| HUP0000564A2 (hu) | 2000-10-28 |
| CN1238690A (zh) | 1999-12-15 |
| EP0941095B1 (en) | 2004-04-21 |
| KR100544248B1 (ko) | 2006-01-23 |
| ES2218705T3 (es) | 2004-11-16 |
| WO1998025621A1 (en) | 1998-06-18 |
| NO992780D0 (no) | 1999-06-08 |
| DE69728783T2 (de) | 2005-03-31 |
| AU5452998A (en) | 1998-07-03 |
| EP0941095A1 (en) | 1999-09-15 |
| CN100413506C (zh) | 2008-08-27 |
| CZ297632B6 (cs) | 2007-02-14 |
| KR20000069360A (ko) | 2000-11-25 |
| NO992780L (no) | 1999-06-08 |
| US5736151A (en) | 1998-04-07 |
| FI991302A0 (fi) | 1999-06-08 |
| CA2269682C (en) | 2009-04-14 |
| AU746666B2 (en) | 2002-05-02 |
| NZ336183A (en) | 2000-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK72399A3 (en) | Pharmaceutical composition | |
| CN1087933C (zh) | 装胶囊的药物 | |
| EP3989968A1 (en) | Oral formulations of edaravone and method of manufacturing thereof | |
| WO2004014390A1 (en) | Novel pharmaceutical composition of ceftiofur | |
| US12295958B2 (en) | Ready-to-use injectable formulations | |
| HK1023292B (en) | Improved pharmaceutical compositions | |
| RU2777360C9 (ru) | Готовые к применению лекарственные формы для инъекций | |
| RU2777360C1 (ru) | Готовые к применению лекарственные формы для инъекций | |
| RU2643327C2 (ru) | Инъецируемые составы антибиотиков и способы их применения | |
| EP2934524B1 (en) | Penethamate veterinary injectable formulations | |
| KR20250048781A (ko) | 에다라본의 경구 제형 및 이의 개선된 제조 방법 | |
| AU2002328168B2 (en) | Novel pharmaceutical composition of ceftiofur | |
| JP2025502120A (ja) | プロゲリニンを含む顆粒剤及びそれを用いたサシェ剤 | |
| WO2014014364A1 (en) | Injectable antibiotic formulations and their methods of use | |
| NZ538144A (en) | Novel pharmaceutical composition of ceftiofur | |
| AU2013364500A1 (en) | Veterinary injectable formulations |